Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Based on the indication, the cardiovascular drugs market is divided into hypertension, hyperlipidemia, coronary artery disease, arrhythmia, and other indications
NHS provision of weight loss medications, including tirzepatide (Zepbound), is governed by eligibility criteria established by the National Institute for Health and Care Excellence (NICE)
Detailed aftercare instructions are provided to support the best possible results
Use separate injection sites and separate syringes
Wegovy: Usually Wegovy injections start at 0.25 milligrams (mg) given once weekly, increasing every 4 weeks through doses of 0.5 mg, 1.0 mg, and 1.7 mg, and eventually reaching a maintenance dose of 2.4 mg
Long-term data from tirzepatide trials extend to 72 weeks, showing continued weight loss with minimal plateauing
US$ 26.84
US$ 26.22
US$ 25.19
US$ 24.10
